Akero Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Akero Therapeutics, Inc. has filed 734 SEC EDGAR filings since 18 Dec 2018

SEC filing history

Showing 151-175 of 734 matching filings.

Per page
25
Current page
7
4

4

Filing date
11 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Feb 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Feb 2025
Reporting date
05 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
31 Jan 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
31 Jan 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Jan 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Jan 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
29 Jan 2025
Reporting date
27 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-279338

FWP

Filing date
28 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jan 2025
Reporting date
24 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
27 Jan 2025
Reporting date
23 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-279338

424B5

Filing date
27 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
27 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
27 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
27 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
27 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
27 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
10 Jan 2025
Reporting date
07 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
02 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Dec 2024
Reporting date
26 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .